Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

As Cronos Stock Skyrockets, Should Investors Be Afraid?

By Chris Lau, InvestorPlace Contributor

Cronos shares have been climbing for months after Altria invested billions in the firm. Is it time to lock in CRON stock profits?

More Marijuana Legalization Will Mean the Sky’s the Limit for Aurora Stock

By Chris Lau, InvestorPlace Contributor

Aurora stock slumped after its earnings report. While some costs are new, the long-term prospects depend on increasing output.

The Main Drivers of Microsoft Stock Are Still Intact

By Chris Lau, InvestorPlace Contributor

Microsoft (NASDAQ: MSFT) stock did not enjoy its usual post-earnings rally. The company issued a conservative forecast, citing weak Windows 10 sales and expectations for ongoing…

Why Buying Sonos After the Dip Is Not a Leap of Faith By Any Measure

By Chris Lau, InvestorPlace Contributor

A small cadre of SONO stock analysts see 50% upside in the shares. Will investors see opportunity in Sonos?

These Catalysts Make Zynga Stock a Buy 2019 and Beyond

By Chris Lau, InvestorPlace Contributor

Strong cost controls despite accelerating revenue growth are propelling shares of Zynga stock to new highs.

Load More